2020
DOI: 10.1016/j.amjcard.2020.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Different Anticoagulation Regimens Regarding Maternal and Fetal Outcomes in Pregnant Patients With Mechanical Prosthetic Heart Valves (from the Multicenter ANATOLIA-PREG Registry)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 27 publications
0
16
0
Order By: Relevance
“…Second, MPHVs are highly thrombogenic, and a pregnancy-induced procoagulant status increases the risk of MPHV thrombosis. 3 , 4 In the presented study, there were 20 (25%) patients who had pregnancy with the MPHV. No detailed information has been given about anticoagulation options in these patients' medical treatments.…”
Section: To the Editormentioning
confidence: 62%
“…Second, MPHVs are highly thrombogenic, and a pregnancy-induced procoagulant status increases the risk of MPHV thrombosis. 3 , 4 In the presented study, there were 20 (25%) patients who had pregnancy with the MPHV. No detailed information has been given about anticoagulation options in these patients' medical treatments.…”
Section: To the Editormentioning
confidence: 62%
“…However, two major studies showed that low-dose slow/ultra-slow infusion t-PA was associated with an excellent maternal clinical outcome and acceptable (similar to the normal population) fetal outcomes. 4,6 While maternal death was not observed in both studies, fetal losses were 20% and 20.6%, respectively. On the other hand, limited number of studies and case reports reveal that the rate of maternal death is 10%-25% and fetal loss can reach 100% after surgical treatment.…”
Section: The Role Of Thrombolytic Therapy In Pregnant Patients With P...mentioning
confidence: 70%
“…3 In fact, we have previously stated that PVT was detected in 32% of patients with strict anti-factor Xa follow-up during pregnancy. 4 In other words, it should be known that this patient population is at risk for PVT even if effective anti-factor Xa follow-up is observed. 4,5 Therefore, there is a need to develop more potent anticoagulation regimens that do not harm the fetus as a new strategy.…”
Section: The Role Of Thrombolytic Therapy In Pregnant Patients With P...mentioning
confidence: 99%
See 1 more Smart Citation
“…After duplicate removal, 247 studies were identified through database search and screened by title and abstract. A total of 37 studies were finally included 1 2 3 5 8 10 12 13 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ( Table 1 ). In 22 of the included studies, data were retrospectively collected, 6 10 12 13 17 18 19 20 21 23 24 25 26 28 32 36 37 38 40 41 42 43 44 whereas 15 studies collected data prospectively.…”
Section: Resultsmentioning
confidence: 99%